DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy. [electronic resource]
Producer: 20120103Description: 2688-98 p. digitalISSN:- 1534-4681
- Adenocarcinoma -- drug therapy
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cisplatin -- administration & dosage
- Clinical Trials, Phase II as Topic
- DNA Repair -- genetics
- DNA, Neoplasm -- genetics
- Esophageal Neoplasms -- drug therapy
- Female
- Fluorouracil -- administration & dosage
- Follow-Up Studies
- Genotype
- Humans
- Male
- Methylenetetrahydrofolate Reductase (NADPH2) -- genetics
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasm Staging
- Polymerase Chain Reaction
- Polymorphism, Genetic -- genetics
- Prospective Studies
- Retrospective Studies
- Stomach Neoplasms -- drug therapy
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.